Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse

Proceedings of the National Academy of Sciences of the United States of America
Anne BraunMonty Krieger

Abstract

Mice with homozygous null mutations in the high-density lipoprotein receptor SR-BI (scavenger receptor class B, type I) and apolipoprotein E genes fed a low-fat diet exhibit a constellation of pathologies shared with human atherosclerotic coronary heart disease (CHD): hypercholesterolemia, occlusive coronary atherosclerosis, myocardial infarctions, cardiac dysfunction (heart enlargement, reduced systolic function and ejection fraction, and ECG abnormalities), and premature death (mean age 6 weeks). They also exhibit a block in RBC maturation and abnormally high plasma unesterified-to-total cholesterol ratio (0.8) with associated abnormal lipoprotein morphology (lamellar/vesicular and stacked discoidal particles reminiscent of those in lecithin/cholesterol acyltransferase deficiency and cholestasis). Treatment with the lipid-lowering, antiatherosclerosis, and antioxidation drug probucol extended life to as long as 60 weeks (mean 36 weeks), and at 5-6 weeks of age, virtually completely reversed the cardiac and most RBC pathologies and corrected the unesterified to total cholesterol ratio (0.3) and associated distinctive abnormal lipoprotein morphologies. Manipulation of the timing of administration and withdrawal of probucol coul...Continue Reading

References

Jul 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M A PfeufferR C Pittman
Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·J P Miller
Jul 25, 1988·The American Journal of Cardiology·G KuR L Jackson
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T KitaC Kawai
Jan 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·E Gjone
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·Y NakashimaR Ross
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·R L ReddickN Maeda
Jun 15, 1997·The Journal of Clinical Investigation·S H ZhangN Maeda
Aug 22, 1997·The Journal of Biological Chemistry·Y JiA R Tall
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A RigottiM Krieger
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·E SehayekJ L Breslow
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·N BergeronR J Havel
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·G CaligiuriG K Hansson
Jul 21, 1999·Kidney International. Supplement·T SugiuraM Hori
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·B TrigattiM Krieger
Jul 6, 2000·Current Opinion in Lipidology·L K Curtiss, W A Boisvert
Jul 11, 2000·Molecular and Cellular Biochemistry·P K SingalN Iliskovic
Aug 11, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·P K WittingR Stocker
Dec 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M E RosenfeldS M Schwartz
Dec 21, 2000·Current Atherosclerosis Reports·K D Pfuetze, C A Dujovne
Mar 7, 2001·Frontiers in Bioscience : a Journal and Virtual Library·D K Swertfeger, D Y Hui
Aug 17, 2001·Current Opinion in Lipidology·R MashimaR Stocker
Sep 7, 2001·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T YoshikawaN Yamada
Dec 6, 2001·The Journal of Clinical Investigation·H E MiettinenM Krieger
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Christopher L AntosEric N Olson

❮ Previous
Next ❯

Citations

Feb 28, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vassilis I ZannisMonty Krieger
Jan 25, 2011·Biochemistry·Thomas J F NielandMonty Krieger
Oct 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kosuke TsukamotoMonty Krieger
Aug 25, 2009·Human Reproduction Update·Victor Y FujimotoRichard W Browne
Apr 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nosratola D VaziriHamid Moradi
Apr 23, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Maryse LemaireKoren K Mann
Mar 17, 2004·Current Opinion in Lipidology·Vassilis I ZannisDimitris Kardassis
May 29, 2004·Current Opinion in Lipidology·Margery A Connelly, David L Williams
Mar 16, 2005·Current Opinion in Lipidology·Ayce YesilaltayMonty Krieger
May 8, 2009·Current Opinion in Lipidology·Olivier Kocher, Monty Krieger
Apr 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Vandana S DoleMonty Krieger
Jun 2, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Alexander BrillDenisa D Wagner
Dec 8, 2007·The Journal of Clinical Investigation·Lei CaiDeneys R van der Westhuyzen
May 22, 2009·Journal of Lipid Research·Reijiro ArakawaShinji Yokoyama
Aug 20, 2011·The Tohoku Journal of Experimental Medicine·Tingting LiYuan Guo
Mar 15, 2008·Redox Report : Communications in Free Radical Research·David TanousRoland Stocker
Jul 23, 2004·Expert Opinion on Therapeutic Targets·W Sean Davidson
Nov 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Ayce YesilaltayMonty Krieger
Oct 27, 2015·The Journal of Nutritional Biochemistry·Regina M KrohnJudit E Smits
Nov 23, 2006·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·James C Russell, Spencer D Proctor
Feb 9, 2012·British Journal of Clinical Pharmacology·Inge De MeyerGuido R Y De Meyer
May 12, 2004·The Journal of Nutritional Biochemistry·Pablo Mardones, Attilio Rigotti
Nov 22, 2005·Molecular and Cellular Endocrinology·Dayami Lopez, Mark P McLean
Nov 3, 2005·Experimental Hematology·Illiana MeursMiranda Van Eck
May 22, 2009·Atherosclerosis·Shizuya Yamashita, Yuji Matsuzawa
Mar 18, 2008·Biochimica Et Biophysica Acta·Olivier KocherMonty Krieger
Jan 31, 2017·Current Opinion in Lipidology·Bernardo L Trigatti
Feb 15, 2007·Journal of Lipid Research·Patricia G YanceyMacRae F Linton
Mar 27, 2016·Journal of Lipid Research·Godfrey S Getz, Catherine A Reardon
Oct 30, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Elda FavariGeorge H Rothblat
Mar 8, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Ling GuoXiang-An Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.